TheraSource, LLC is a growing biotech company based in the Greater New York Area that specializes in discovering novel therapeutics for inflammatory diseases. They develop and utilize innovative technologies, such as recombinant proteins and peptides, to treat various human diseases.
With a focus on cutting-edge research, TheraSource has made significant advancements in the field of medical science. Their expertise extends to areas such as acute kidney injury, hemorrhagic shock, inflammatory bowel disease, acute ischemic stroke, acute radiation syndrome, and sepsis. Through partnerships and participation in workshops, TheraSource actively contributes to the development of new treatments and countermeasures for these conditions.
Generated from the website